Fig. 4
From: Stroke recovery phenotyping through network trajectory approaches and graph neural networks
Trajectory profiles (same as in the above figure) were applied independently on patients that A received tissue plasminogen activator (tPA) treatment within 3 h of stroke onset compared to B patients who received placebo. Subtypes identified by the algorithm containing fewer than 10 patients are not shown (1 outlier patient falls under this category). The shade of grey indicates the affected fraction